Aspirin protects against preeclampsia via p38MAPK signaling pathway

被引:3
|
作者
Su, Min [1 ]
Zhou, Binying [1 ]
Zhen, Manhua [1 ]
Liu, Jiasi [1 ]
机构
[1] Foshan Fosun Chancheng Hosp, Dept Obstet & Gynecol, Foshan 528031, Guangdong, Peoples R China
关键词
Aspirin; p38MAPK; Preeclampsia; Protective effect; PREVENTION; WOMEN;
D O I
10.4314/tjpr.v21i12.8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To investigate the protective effect of aspirin against preeclampsia and the involvement of p38MAPK signaling pathway in the process. Methods: Sixty pregnant women who underwent antenatal care and delivery at Chancheng Central Hospital from September 2020 to September 2022 were selected and equally assigned to control group (CG) and experimental group (EG). From the 12th week of gestation, EG was administered 100 mg of aspirin and 1000 mg of calcium carbonate daily, while CG was given only 1000 mg of calcium carbonate daily. Both groups were treated up to the 35th week of gestation. Thereafter, blood samples were taken for measurement of serum levels of p38MAPK. In addition, the blood pressure of the women was measured. The incidence of preeclampsia and maternal-infant outcomes were assessed. Results: EG had a lower p38MAPK level at week 35 of pregnancy, and lower blood pressure levels at the 27th and 35th weeks of gestation, than CG (p < 0.05). There were 5 cases of preeclampsia (16.7 %) in EG, and 13 cases (43.3 %) of preeclampsia in CG, with a lower incidence of preeclampsia in EG than in CG (chi(2) = 5.079, p < 0.05). The numbers of newborns through premature delivery and cesarean section, as well as Apgar score <= 7 were lower in EG than in CG (p < 0.05). Conclusion: Aspirin exerts a protective effect against preeclampsia through via p38MAPK signaling pathway. Therefore, aspirin treatment may be useful in reducing the incidence of preeclampsia and improving maternal-infant outcomes. However, further clinical trials are recommended prior to application in clinical practice.
引用
收藏
页码:2555 / 2560
页数:6
相关论文
共 50 条
  • [21] Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway
    Li, Shaocong
    He, Qi
    Chen, Baihao
    Zeng, Jiaxu
    Dou, Xiangyun
    Pan, Zhaofeng
    Xiao, Jiacong
    Li, Miao
    Wang, Fanchen
    Chen, Chuyi
    Lin, Yuewei
    Wang, Xintian
    Wang, Haibin
    Chen, Jianfa
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway
    Shaocong Li
    Qi He
    Baihao Chen
    Jiaxu Zeng
    Xiangyun Dou
    Zhaofeng Pan
    Jiacong Xiao
    Miao Li
    Fanchen Wang
    Chuyi Chen
    Yuewei Lin
    Xintian Wang
    Haibin Wang
    Jianfa Chen
    Scientific Reports, 13
  • [23] Contribution of the p38MAPK Signaling Pathway and the Egr-1 Transcription Factor in Glomerulosclerosis
    Braz, Heitor Macedo
    Oliveira-Souza, Maria
    Lopes, Guilherme Goncalves
    Pessoa, Juliana Martins da Costa
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Dexmedetomidine alleviates hyperalgesia in arthritis rats through inhibition of the p38MAPK signaling pathway
    Nie, Bin
    Jiang, Hui
    Chen, Hong
    Liu, Qiong
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (04) : 586 - 593
  • [25] The p38MAPK signaling pathway regulates neuronal apoptosis through the phosphorylation of the retinoblastoma protein
    Yeste-Velasco, Marc
    Folch, Jaume
    Pallas, Merce
    Camins, Antoni
    NEUROCHEMISTRY INTERNATIONAL, 2009, 54 (02) : 99 - 105
  • [26] Activation of P38MAPK signaling cascade in a VSMC injury model: Role of P38MAPK inhibitors in limiting VSMC proliferation
    Jacob, T
    Ascher, E
    Alapat, D
    Olevskaia, Y
    Hingorani, A
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2005, 29 (05) : 470 - 478
  • [27] Hydrogen suppresses oxidative stress by inhibiting the p38 MAPK signaling pathway in preeclampsia
    Guo, Lili
    Liu, Ming
    Duan, Tao
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 32 (03): : 357 - 367
  • [28] TNFRSF9 Suppressed the Progression of Breast Cancer via the p38MAPK/PAX6 Signaling Pathway
    Liu, Xiaorong
    Zhou, Yehui
    Qin, Chenglin
    Zhu, Xun
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [29] Mitochondrial-generated ROS down regulates insulin signaling via activation of the p38MAPK stress response pathway
    Al-Lahham, Rabab
    Deford, James H.
    Papaconstantinou, John
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 419 (0C) : 1 - 11
  • [30] RIG-I acts as a tumor suppressor in melanoma via regulating the activation of the MKK/p38MAPK signaling pathway
    Rui Guo
    Shun-Yuan Lu
    Jin-Xia Ma
    Qian-Lan Wang
    Lu Zhang
    Ling-Yun Tang
    Yan Shen
    Chun-Ling Shen
    Jin-Jin Wang
    Li-Ming Lu
    Zhu-Gang Wang
    Hong-Xin Zhang
    Human Cell, 2022, 35 : 1071 - 1083